LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 13 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 3. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 13 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 3. - Dataset (ID:20250)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 107 of 166
Next
>>
>
2651 to 2675 of 4140 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Timepoint	Timepoint Unit	Mean Total Cell Count Before Treatment	Mean Total Cell Count After Treatment	Mean Total Control Cell Count	Mean Relative Cell Count	Mean Normalized Growth Rate Inhibition Value
BT-20	Pelitinib	3.33	uM	LJP5	72	hr	1097	2256	3846	0.5870	0.4897
BT-20	Pelitinib	10	uM	LJP5	72	hr	1097	807	3846	0.2097	-0.1571
BT-20	Luminespib	0.04	uM	LJP5	72	hr	1097	1146	3846	0.2983	0.0243
BT-20	Luminespib	0.12	uM	LJP5	72	hr	1097	1164	3846	0.3029	0.0333
BT-20	Luminespib	0.37	uM	LJP5	72	hr	1097	1128	3846	0.2936	0.0153
BT-20	Luminespib	1.11	uM	LJP5	72	hr	1097	1155	3846	0.3004	0.0287
BT-20	Luminespib	3.33	uM	LJP5	72	hr	1097	1139	3846	0.2964	0.0209
BT-20	Luminespib	10	uM	LJP5	72	hr	1097	1241	3846	0.3228	0.0703
BT-20	AZD8330	0.04	uM	LJP5	72	hr	1097	2875	3846	0.7480	0.7034
BT-20	AZD8330	0.12	uM	LJP5	72	hr	1097	2907	3846	0.7558	0.7129
BT-20	AZD8330	0.37	uM	LJP5	72	hr	1097	2988	3846	0.7769	0.7394
BT-20	AZD8330	1.11	uM	LJP5	72	hr	1097	2914	3846	0.7572	0.7141
BT-20	AZD8330	3.33	uM	LJP5	72	hr	1097	3168	3846	0.8252	0.7981
BT-20	AZD8330	10	uM	LJP5	72	hr	1097	3259	3846	0.8483	0.8263
BT-20	TGX221	0.04	uM	LJP5	72	hr	1097	3685	3846	0.9588	0.9542
BT-20	TGX221	0.12	uM	LJP5	72	hr	1097	3695	3846	0.9605	0.9552
BT-20	TGX221	0.37	uM	LJP5	72	hr	1097	3823	3846	0.9940	0.9932
BT-20	TGX221	1.11	uM	LJP5	72	hr	1097	4111	3846	1.0690	1.0745
BT-20	TGX221	3.33	uM	LJP5	72	hr	1097	4159	3846	1.0807	1.0868
BT-20	TGX221	10	uM	LJP5	72	hr	1097	3970	3846	1.0325	1.0357
BT-20	GSK1059615	0.04	uM	LJP5	72	hr	1097	3637	3846	0.9448	0.9368
BT-20	GSK1059615	0.04	uM	LJP6	72	hr	1097	3105	3673	0.8451	0.8155
BT-20	GSK1059615	0.12	uM	LJP5	72	hr	1097	2863	3846	0.7439	0.6977
BT-20	GSK1059615	0.12	uM	LJP6	72	hr	1097	2383	3673	0.6489	0.5601
BT-20	GSK1059615	0.37	uM	LJP5	72	hr	1097	1427	3846	0.3714	0.1567

|<
<<
Previous
Page 107 of 166
Next
>>
>
2651 to 2675 of 4140 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 13 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 3. - Dataset (ID:20250)